ivory finale low-dose interleukin-2 for the reduction of vascular inflammation in acs - esc 2024
Published 2 months ago • 507 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
4:21
esc tv at aha 2018 - the cardiovascular inflammation reduction trial (cirt)
-
59:37
2023 esc guidelines for the management of acute coronary syndromes
-
12:11
acute coronary syndrome: clinical sciences
-
53:55
medicine grand rounds: 2023 esc guidelines for the management of acute coronary syndromes – 11/7/23
-
3:42
esc tv 2014 - acute coronary syndrome
-
6:46
esc 23: new guidelines for the management of acute coronary syndromes
-
3:52
esc 2015: dose lowering inflammation lower vascular risk? paul ridker m.d
-
14:32
esc guidelines: specific cvds & mutlimorbidity (english version)
-
58:49
managing triple therapy in acs
-
38:54
completeness of revascularisation in acute coronary syndrome patients with multivessel disease - h2h
-
2:20
esc tv at #esccongress 2021 - stopdapt-2 acs
-
5:12
european challenges in the management of acs
-
3:59
acute coronary syndrome, summary of the 2023 esc guidelines: a new chapter in the pcr-eapci textbook
-
4:02
esc 23: stopdapt-3: prasugrel monotherapy without aspirin in acute coronary syndrome patients
-
18:52
reducing the risk of acute coronary syndrome (acs)
-
15:14
acute coronary syndrome ( kenichi fujise, md) saturday, august 20, 2016
-
52:11
advances in dual antiplatelet therapy for acute coronary syndrome (acs)
-
1:14:29
best of esc congress 2015 - 3 september 2015